The Bangladeshi government has approved the purchase of 15 million doses of Covid-19 vaccine in China.
Additional Cabinet Division Secretary Shahida Akhter told the media on Thursday that each dose of the Chinese Sinopharm vaccine will be priced at $ 10.
From June, shipments will arrive in Bangladesh in three phases, with five million doses in each shipment, bdnews24 reported.
This comes after a government cabinet committee approved the $ 150 million government-to-government vaccination agreement at a meeting in the capital Dhaka. According to bdnews24, this means that no private company in Bangladesh will be part of the deal.
Bangladesh had begun its coronavirus inoculation with the Oxford-AstraZeneca vaccine acquired in India at $ 5 per dose. As things stand, the Chinese vaccine will cost Bangladesh twice as much as the Oxford-AstraZeneca shot from India’s serum.
In the last 24 hours to Saturday morning, Bangladesh recorded another 38 deaths and 1,043 cases of COVID-19, the Dhaka Tribune reported. The total number of infections in the country rises to 797,386 and the number of deaths stands at 12,549.
(Only the title and image of this report may have been reworked by Business Standard staff; the rest of the content is automatically generated from a syndicated feed.)
Business Standard has always strived to provide up-to-date information and feedback on developments that are of interest to you and that have broader economic and political implications for the country and the world. Your encouragement and constant comments on how to improve our offer have only strengthened our determination and commitment to these ideals. Even during these difficult times arising from Covid-19, we continue to remain committed to keeping you informed and up to date with credible news, authoritative opinions, and incisive comments on topical issues of relevance.
However, we have a request.
As we fight the economic impact of the pandemic, we need your support even more so that we can continue to offer you more quality content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscription to our online content can only help us achieve our goals of providing you with even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism we are committed to.
Support quality journalism and subscribe to Business Standard.